Mariluz Ortiz, SW,MCMHC | |
Santander Securities Plaza Hostos #349, Suite 104, Mayaguez, PR 00680 | |
(787) 265-2300 | |
(787) 831-1714 |
Full Name | Mariluz Ortiz |
---|---|
Gender | Female |
Speciality | Social Worker - Clinical |
Location | Santander Securities Plaza Hostos #349, Mayaguez, Puerto Rico |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1760876536 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YM0800X | Counselor - Mental Health | 1858 (Puerto Rico) | Secondary |
1041C0700X | Social Worker - Clinical | 8144 (Puerto Rico) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mariluz Ortiz, SW,MCMHC Villa San Andres # 349, Suite 104, Mayaguez, PR 00680-5704 Ph: (787) 265-2300 | Mariluz Ortiz, SW,MCMHC Santander Securities Plaza Hostos #349, Suite 104, Mayaguez, PR 00680 Ph: (787) 265-2300 |
News Archive
While regular multivitamin use is not linked with early or localized prostate cancer, taking too many multivitamins may be associated with an increased risk for advanced or fatal prostate cancers, according to a study in the May 16 issue of the Journal of the National Cancer Institute.
Medical Care Technologies Inc. today announced that it has been developing its latest medical device technology - Heart Vital Signs ("HVS") to be included as an add-on to its Tele-Healthâ„¢ Suite. Remote cardiac monitoring technologies allow home electrocardiographic (ECG) monitoring of patients with suspected cardiac arrhythmias or at risk for developing arrhythmias.
The number of general surgeons per 100,000 Americans has declined by more than 25 percent during the past 25 years, according to a report in the April issue of Archives of Surgery.
HemoShear LLC, a biotechnology research company and leading developer of human cell-based surrogate systems for discovery and assessment of new drug compounds, today announced that the U.S. Patent and Trademark Office (USPTO) has granted it patent no. 7,811,782 entitled "Use of An In Vitro Hemodynamic Endothelial/Smooth Muscle Cell Co-Culture Model to Identify New Therapeutic Targets for Vascular Disease."
› Verified 6 days ago